Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Faculty Opinions recommendation of Antitumor activity of a novel antisense oligonucleotide against Akt1. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Antitumor activity of a novel antisense oligonucleotide against Akt1.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Antitumor activity of a novel antisense oligonucleotide against Akt1.
Dataset
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Modulation of the antitumor immune response by complement.
Alberto Mantovani
Dataset
Faculty Opinions recommendation of Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.
Alberto Mantovani
DOI
10.3410/f.1343959.815057
Year
Published
—
Language
en
Dataset Details
Link Of The Paper
https://doi.org/10.3410/f.1343959.815057
Timeline
Created:
June 19, 2026
Dataset
Faculty Opinions recommendation of Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of MYC regulates the antitumor immune response through CD47 and PD-L1.
Alberto Mantovani
Article
2002
Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis
Michael J.B. Kutryk
,
David P. Foley
,
Marcel van den Brand
,
J Hamburger
,
Willem J. van der Giessen
,
Pim J. deFeyter
,
Nico Bruining
,
Manel Sabaté
,
Patrick W. Serruys
Journal of the American College of Cardiology
Discussion(0)
No comments yet. Be the first to comment.